Company intelligence / Profile preview

Yantai Dongcheng Pharmaceutical

Yantai, Shandong, Chinadcb-group.com ↗
Ownership
Private
Employees
~2469
Development stage
Phase 1
01

Overview

Yantai Dongcheng Pharmaceutical is a leading Chinese pharmaceutical group with a strong focus on biochemical APIs and radiopharmaceuticals. The company has multiple approved products in China and globally for both diagnostic and therapeutic use in oncology and other indications. It holds significant market share in PET tracers in China and maintains robust R&D capabilities with several late-stage clinical programs targeting solid tumors using innovative radionuclide therapies.

Therapeutic areas
Men's HealthOncologyImmunologyRheumatologyCardiovascular
Modalities
Small moleculePeptidesRadiopharmaceuticals (Therapeutic radiopharmaceuticals, Diagnostic radiopharmaceuticals)
Industry
Biotech
02

Drug pipeline

2 assets

消风止痒颗粒

Unknown

1 more asset in the full pipeline.

03

Partnerships

ImaginAb Inc. – exclusive license for CD8 ImmunoPET agent in Greater China marketGE Healthcare – supply/commercialization partnership for radio-pharmacies network in ChinaNihon Medi‑Physics/NMP – collaboration on nuclear medicine products/distribution network

Beyond the preview

Go deeper on Yantai Dongcheng Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yantai Dongcheng Pharmaceutical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call